Impute.me

France Founded: 2015 • Age: 11 yrs Acquired By Nucleus Genomics
Non-profit tools utilizing data services are provided by Impute.me.

About Impute.me

Impute.me is a Government & Social Sector company based in France founded in 2015, and was acquired by Nucleus Genomics in July 2022. Non-profit tools utilizing data services are provided by Impute.me. Its focus areas include Nonprofits and Foundations. Its legal entity is 24Genetics Inc.

Company details

Impute.me was established in 2015 in France as a provider of non-profit tools that leverage data services. Operations center on delivering imputation and analysis functionalities for genetic and health data, supporting research and personalization efforts. The company functions within the data services sector, emphasizing open-access resources for scientific communities across Europe and beyond. Services are maintained through an online platform accessible via its domain.

  • Headquarters France
  • Stage Acquired
  • Sectors
    Government & Social Sector
  • Website impute.me
  • Social X
  • Acquired by Nucleus Genomics (Jul 2022)
  • Legal Name 24Genetics Inc
Key Metrics

Investors in Impute.me

Impute.me has secured backing from 1 investor. Prominent investors backing the company include Nucleus Genomics.

All
InvestorDescriptionFounded YearDomainLocation
Provider of genetic testing kits for rare variant analysis
2021mynucleus.comManhattan, United States
Premium access

Investor details for Impute.me

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Impute.me

2 dated milestones of Impute.me across 7 years, from founding to its latest funding, stage changes and deals.

  1. Founded Impute.me is founded.
  2. Exit Acquired by Nucleus Genomics.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Impute.me

Impute.me was founded in 2015.

Impute.me is headquartered in France.

Impute.me was established in 2015 in France as a provider of non-profit tools that leverage data services. Operations center on delivering imputation and analysis functionalities for genetic and health data, supporting research and personalization efforts. The company functions within the data services sector, emphasizing open-access resources for scientific communities across Europe and beyond. Services are maintained through an online platform accessible via its domain.

Impute.me has 1 investor. Key investors include Nucleus Genomics.

Impute.me operates through 24Genetics Inc.

Yes. Impute.me was acquired by Nucleus Genomics in July 2022.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available